EP1206249A4 - Hydrodynamically balancing oral drug delivery system - Google Patents

Hydrodynamically balancing oral drug delivery system

Info

Publication number: EP1206249A4
Authority: EP; European Patent Office
Prior art keywords: hydrodynamically; delivery system; drug delivery; oral drug; balancing
Prior art date: 1999-08-04
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP00949840A

Other languages

German (de)

French (fr)

Other versions

EP1206249A1 (en

Inventor

Naresh Talwar

John N Staniforth

Michael J Tobyn

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ranbaxy Laboratories Ltd

Original Assignee

Ranbaxy Laboratories Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-08-04

Filing date

2000-08-01

Publication date

2004-12-22

2000-08-01 Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd

2002-05-22 Publication of EP1206249A1 publication Critical patent/EP1206249A1/en

2004-12-22 Publication of EP1206249A4 publication Critical patent/EP1206249A4/en

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EP00949840A 1999-08-04 2000-08-01 Hydrodynamically balancing oral drug delivery system Withdrawn EP1206249A4 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
WOPCT/IB99/01386		1999-08-04
PCT/IB1999/001386 WO2001010405A1 (en)	1999-08-04	1999-08-04	Hydrodynamically balanced oral drug delivery system
PCT/IB2000/001083 WO2001010419A1 (en)	1999-08-04	2000-08-01	Hydrodynamically balancing oral drug delivery system

Publications (2)

Publication Number	Publication Date
EP1206249A1 EP1206249A1 (en)	2002-05-22
EP1206249A4 true EP1206249A4 (en)	2004-12-22

Family

ID=11004886

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP00949840A Withdrawn EP1206249A4 (en)	1999-08-04	2000-08-01	Hydrodynamically balancing oral drug delivery system

Country Status (21)

Country	Link
EP (1)	EP1206249A4 (en)
JP (1)	JP2003506400A (en)
CN (1)	CN1376059A (en)
AP (1)	AP2002002410A0 (en)
AU (2)	AU5060499A (en)
BR (1)	BR0012981A (en)
CA (1)	CA2378468A1 (en)
CZ (1)	CZ2002415A3 (en)
EA (1)	EA200200126A1 (en)
HK (1)	HK1047226A1 (en)
HR (1)	HRP20020108A2 (en)
HU (1)	HUP0202497A3 (en)
IL (1)	IL147966A0 (en)
MX (1)	MXPA02001272A (en)
NZ (1)	NZ516959A (en)
OA (1)	OA12003A (en)
PL (1)	PL353321A1 (en)
SK (1)	SK1832002A3 (en)
TR (1)	TR200200467T2 (en)
WO (2)	WO2001010405A1 (en)
ZA (1)	ZA200200926B (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100457458B1 (en) *	2001-04-02	2004-11-17	삼아약품 주식회사	Rapidly dissolving tablet and process for preparing same
MXPA03012041A (en)	2001-07-04	2004-03-26	Sun Pharmaceutical Ind Ltd	Gastric retention controlled drug delivery system.
CA2466032A1 (en) *	2001-10-29	2003-05-08	Laure Patricia Ouadji Njiki	Methods and dosage forms for improving the bioavailability of therapeutic agents
US20050226926A1 (en)	2002-07-25	2005-10-13	Pfizer Inc	Sustained-release tablet composition of pramipexole
CA2536906A1 (en) *	2003-08-27	2005-03-10	Vecta Ltd.	Compositions for treating pathologies that necessitate suppression of gastric acid secretion
TW200533391A (en) *	2004-03-25	2005-10-16	Sun Pharmaceutical Ind Ltd	Gastric retention drug delivery system
JP4785847B2 (en)	2004-08-13	2011-10-05	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Tablet formulation with extended release comprising pramipexole or a pharmaceutically acceptable salt thereof, process for its production and use thereof
DE102004042139B4 (en) *	2004-08-31	2009-06-10	Aristocon Verwaltungs- Gmbh	Peroral dosage forms to achieve a retarding effect after drug intake with a meal
EP1690540A1 (en) *	2005-02-15	2006-08-16	Neuro3D	Composition comprising ocaperidone
AU2006330526B2 (en)	2005-12-22	2012-09-27	Oakwood Laboratories, Llc	Sublimable sustained release delivery system and method of making same
EP1886665A1 (en) *	2006-08-01	2008-02-13	Boehringer Ingelheim Pharma GmbH & Co. KG	Gastro retentive delivery system
CN101652128B (en) *	2007-03-02	2012-12-19	法纳姆公司	Sustained release compositions using wax-like materials
MX340249B (en)	2008-08-15	2016-07-01	Depomed Inc	Gastric retentive pharmaceutical compositions for treatment and prevention of cns disorders.
KR20110042366A (en)	2008-08-18	2011-04-26	팀 아카데미 오브 파마슈티컬 사이언스	Gastrointestinal drug delivery systems, methods of manufacture and their use
US9622977B2 (en)	2008-10-08	2017-04-18	Bioplus Life Sciences Pvt, Ltd.	Sustained release drug delivery system
EP2283824B1 (en)	2009-07-30	2017-04-19	Special Products Line S.p.A.	Compositions and formulations based on swellable matrices for sustained release of poorly soluble drugs such as clarithromycin
JP2013103879A (en) *	2011-11-10	2013-05-30	Nakanihon Capsule Co Ltd	Hard capsule
KR102241487B1 (en)	2013-02-20	2021-04-16	주식회사 종근당	Pharmaceutical composition consisting of sustained-release pellets
WO2014144661A1 (en) *	2013-03-15	2014-09-18	Aprecia Pharmaceuticals Compny	Rapidly dispersible dosage form of topiramate
CN103462917A (en) *	2013-09-12	2013-12-25	南京正宽医药科技有限公司	Antiviral acyclovir tablet and preparation method thereof
EP3468382A4 (en) *	2016-06-14	2020-01-22	Prevtec Microbia Inc	Animal feed pellets including a feed additive, method of making and of using same
DK3648747T3 (en) *	2017-06-16	2022-11-28	Amneal Complex Products Res Llc	Gastroretentive dosage forms for sustained release of drugs
US10588863B2 (en)	2017-06-16	2020-03-17	Kashiv Biosciences, Llc	Extended release compositions comprising pyridostigmine
US10987311B2 (en)	2017-06-16	2021-04-27	Kashiv Specialty Pharmaceuticals, Llc	Extended release compositions comprising pyridostigmine
CN107441115A (en) *	2017-08-22	2017-12-08	安徽省肿瘤医院	A kind of purposes of Verapamil joint sodium acid carbonate in primary liver cancer medicine is prepared
CN107375287B (en) *	2017-08-22	2019-11-29	安徽省肿瘤医院	A kind of purposes of atropine sulfate in preparation treatment Primary Hepatic cancer drug
CN107349195A (en) *	2017-08-22	2017-11-17	安徽省肿瘤医院	A kind of Verapamil is preparing the purposes in treating metastatic hepatic carcinoma medicine
EP4056172A1 (en)	2018-06-18	2022-09-14	Amneal Complex Products Research LLC	Extended release compositions comprising pyridostigmine
US10744083B2 (en)	2018-06-27	2020-08-18	Kashiv Biosciences, Llc	Self-regulating osmotic gastroretentive drug delivery systems
WO2020230089A1 (en)	2019-05-14	2020-11-19	Clexio Biosciences Ltd.	Treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease
WO2022195476A1 (en)	2021-03-15	2022-09-22	Clexio Biosciences Ltd.	Gastroretentive devices for assessment of intragastric conditions

Citations (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3909520A1 (en) *	1988-03-25	1989-10-05	Ciba Geigy Ag	SOLID, FAST CLEARING PHARMACEUTICAL FORMS
WO1993013760A1 (en) *	1992-01-13	1993-07-22	Gerhard Gergely	Pharmaceutical preparation in the form of an effervescent and/or disintegrating tablet or an instant granulate, and process for producing it
GB2283172A (en) *	1993-10-29	1995-05-03	Scherer Ltd R P	Gelatin capsules
EP0667151A1 (en) *	1994-02-08	1995-08-16	Hexal Pharma GmbH	Oral drug formulation containing diclofenac Sodium
WO1996008238A1 (en) *	1994-09-14	1996-03-21	Glaxo Group Limited	Use of paracellular absorption enhancers such as glucose for enhaincing the absorption of histamine h2-antagonists
WO1998032425A1 (en) *	1997-01-29	1998-07-30	Poli Industria Chimica S.P.A.	Pharmaceutical formulations with delayed drug release
WO1999004765A2 (en) *	1997-07-23	1999-02-04	Chiesi Farmaceutici S.P.A.	Pharmaceutical compositions containing an effervescent acid-base couple

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5096714A (en) *	1988-06-28	1992-03-17	Hauser-Kuhrts, Inc.	Prolonged release drug tablet formulations
DE69017915T2 (en) *	1989-10-26	1995-07-27	Nippon Shinyaku Co Ltd	PREPARATION FOR THE STOMACH.

1999
- 1999-08-04 AU AU50604/99A patent/AU5060499A/en not_active Abandoned
- 1999-08-04 WO PCT/IB1999/001386 patent/WO2001010405A1/en active Application Filing
- 1999-08-04 AP APAP/P/2002/002410A patent/AP2002002410A0/en unknown
2000
- 2000-08-01 TR TR2002/00467T patent/TR200200467T2/en unknown
- 2000-08-01 HU HU0202497A patent/HUP0202497A3/en unknown
- 2000-08-01 AU AU63099/00A patent/AU774957B2/en not_active Ceased
- 2000-08-01 JP JP2001514939A patent/JP2003506400A/en active Pending
- 2000-08-01 SK SK183-2002A patent/SK1832002A3/en unknown
- 2000-08-01 EP EP00949840A patent/EP1206249A4/en not_active Withdrawn
- 2000-08-01 BR BR0012981-0A patent/BR0012981A/en not_active IP Right Cessation
- 2000-08-01 MX MXPA02001272A patent/MXPA02001272A/en not_active Application Discontinuation
- 2000-08-01 WO PCT/IB2000/001083 patent/WO2001010419A1/en not_active Application Discontinuation
- 2000-08-01 CN CN00813344A patent/CN1376059A/en active Pending
- 2000-08-01 IL IL14796600A patent/IL147966A0/en unknown
- 2000-08-01 NZ NZ516959A patent/NZ516959A/en unknown
- 2000-08-01 PL PL00353321A patent/PL353321A1/en not_active Application Discontinuation
- 2000-08-01 CA CA002378468A patent/CA2378468A1/en not_active Abandoned
- 2000-08-01 OA OA1200200041A patent/OA12003A/en unknown
- 2000-08-01 CZ CZ2002415A patent/CZ2002415A3/en unknown
- 2000-08-01 EA EA200200126A patent/EA200200126A1/en unknown
2002
- 2002-02-01 ZA ZA200200926A patent/ZA200200926B/en unknown
- 2002-02-04 HR HR20020108A patent/HRP20020108A2/en not_active Application Discontinuation
- 2002-11-22 HK HK02108477.3A patent/HK1047226A1/en unknown

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3909520A1 (en) *	1988-03-25	1989-10-05	Ciba Geigy Ag	SOLID, FAST CLEARING PHARMACEUTICAL FORMS
WO1993013760A1 (en) *	1992-01-13	1993-07-22	Gerhard Gergely	Pharmaceutical preparation in the form of an effervescent and/or disintegrating tablet or an instant granulate, and process for producing it
GB2283172A (en) *	1993-10-29	1995-05-03	Scherer Ltd R P	Gelatin capsules
EP0667151A1 (en) *	1994-02-08	1995-08-16	Hexal Pharma GmbH	Oral drug formulation containing diclofenac Sodium
WO1996008238A1 (en) *	1994-09-14	1996-03-21	Glaxo Group Limited	Use of paracellular absorption enhancers such as glucose for enhaincing the absorption of histamine h2-antagonists
WO1998032425A1 (en) *	1997-01-29	1998-07-30	Poli Industria Chimica S.P.A.	Pharmaceutical formulations with delayed drug release
WO1999004765A2 (en) *	1997-07-23	1999-02-04	Chiesi Farmaceutici S.P.A.	Pharmaceutical compositions containing an effervescent acid-base couple

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0110419A1 *

Also Published As

Publication number	Publication date
BR0012981A (en)	2002-06-18
HRP20020108A2 (en)	2003-12-31
CN1376059A (en)	2002-10-23
TR200200467T2 (en)	2002-08-21
EP1206249A1 (en)	2002-05-22
AU774957B2 (en)	2004-07-15
AU6309900A (en)	2001-03-05
OA12003A (en)	2006-04-18
EA200200126A1 (en)	2002-10-31
PL353321A1 (en)	2003-11-17
HUP0202497A2 (en)	2002-11-28
AP2002002410A0 (en)	2002-03-31
CZ2002415A3 (en)	2002-08-14
SK1832002A3 (en)	2002-08-06
HK1047226A1 (en)	2003-02-14
JP2003506400A (en)	2003-02-18
WO2001010405A1 (en)	2001-02-15
CA2378468A1 (en)	2001-02-15
MXPA02001272A (en)	2002-07-22
NZ516959A (en)	2003-10-31
ZA200200926B (en)	2002-11-27
WO2001010419A1 (en)	2001-02-15
HUP0202497A3 (en)	2004-05-28
IL147966A0 (en)	2002-09-12
AU5060499A (en)	2001-03-05

Publication	Publication Date	Title
HRP20020108A2 (en)	2003-12-31	Hydrodynamically balancing oral drug delivery system
GB9904629D0 (en)	1999-04-21	Oral drug delivery system
HK1072177A1 (en)	2005-08-19	Drug delivery device
AU7333601A (en)	2002-01-21	Drug delivery management system
AU2123200A (en)	2000-08-18	Drug delivery device
AU2002302890A1 (en)	2003-12-02	Hydrodynamically balancing oral drug delivery system with biphasic release
EP1061987A4 (en)	2003-04-09	Drug delivery system
AU3520900A (en)	2000-09-28	Implantable drug delivery system
EP1087753A4 (en)	2004-06-30	Targeted liposomal drug delivery system
EP0989878A4 (en)	2000-10-25	Drug delivery system
EP1021137A4 (en)	2000-12-06	Drug delivery system
GB2352314B (en)	2003-11-26	Delivery system
GB0011066D0 (en)	2000-06-28	Delivery system
GB0029843D0 (en)	2001-01-24	Drug delivery system
GB9930160D0 (en)	2000-02-09	Drug delivery
GB9914960D0 (en)	1999-08-25	Delivery system
AU2002210580A1 (en)	2002-04-29	Drug delivery system
GB9901133D0 (en)	1999-03-10	Drug delivery system
GB9902509D0 (en)	1999-03-24	Drug delivery system
GB9905134D0 (en)	1999-04-28	Medicament delivery system
GB9917470D0 (en)	1999-09-29	Medicament delivery system
GB9923273D0 (en)	1999-12-08	Medicament delivery system
GB9800835D0 (en)	1998-03-11	Drug delivery system
AU4808000A (en)	2000-11-10	Drug delivery system
GB9904304D0 (en)	1999-04-21	Drug delivery

Legal Events

Date	Code	Title	Description
2002-04-05	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2002-05-22	17P	Request for examination filed	Effective date: 20020304
2002-05-22	AX	Request for extension of the european patent	Free format text: AL;LT;LV;MK;RO;SI PAYMENT 20020304
2004-12-22	A4	Supplementary search report drawn up and despatched	Effective date: 20041109
2007-01-10	17Q	First examination report despatched	Effective date: 20061211
2007-08-03	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2007-09-05	18D	Application deemed to be withdrawn	Effective date: 20070301
2009-03-13	REG	Reference to a national code	Ref country code: HK Ref legal event code: WD Ref document number: 1047226 Country of ref document: HK